Tel.: 514-340-8222
Dr. Gerald Batist, MD FACP
Deputy Director and Senior Investigator, Lady Davis Institute
Minda de Gunzburg Professor of Oncology, McGill University
Director, Segal Cancer Centre, Jewish General Hospital
Director, McGill Centre for Translational Research in Cancer, Lady Davis Institute

Dr. Batist's Publications Indexed on PubMed
Dr. Gerald Batist was Chairman of the Department of Oncology, McGill University from 2001 until 2011. He is Director of the McGill Centre for Translational Research in Cancer (MCTRC), which was established to stimulate rapid translation of new discoveries in the research laboratory into clinical benefits for patients. A major award from the Canada Foundation for Innovation allowed for the MCTRC to be expanded to create the Montreal Centre for Experimental Therapeutics in Cancer (MCETC), now a major component of the Segal Cancer Centre at the Jewish General Hospital, which also serves as the Experimental Therapeutics Axis of the Réseau de recherche sur le cancer of the Fonds de la recherche en santé du Québec (FRSQ). He is also Director of the Segal Cancer Centre.
In 2007, together with Dr. Luc Bélanger, Director of the Centre de recherche en cancérologie de l’Université Laval at l’ Hôtel Dieu de Quebec (CHUQ), Dr. Batist co-founded the Quebec – Clinical Research Organization in Cancer (Q-CROC), which focuses on biomarker-driven clinical trials and therapeutic resistance. It is also active in oncology care. Q-CROC operates as a network that brings together basic and clinician researchers, oncologists, surgeons and pathologists, among others. Its firm intention is to establish a province-wide translational and clinical research infrastructure in oncology.
Dr. Batist was born in Montreal. After beginning his university studies in New York City, he returned to attend medical school at McGill University. This was followed by post-doctoral training in New York, Boston, and, finally, at the National Cancer Institute in Washington, where he trained in medical oncology and molecular pharmacology.
Dr. Batist’s research programs are in novel therapeutics, and he’s made significant contributions to the development of new cancer treatments. In his capacity as Chairman of Oncology at McGill, he has nurtured the development of a number of multidisciplinary programs that have been highly innovative and are among the first of their kind in Canada. He leads a highly successful laboratory and clinical research program, which has been credited with over 180 scientific publications and a number of book chapters. He has trained many scientists and clinical oncologists, and also practices medical oncology. 
Recent Publications

Spatz A, Stock N, Batist G, van Kempen LC., “The biology of melanoma prognostic factors” Discov Med. 2010 Jul;10(50):87-93.
Mokrani N, Felfoul O, Afkhami Zarreh F, Mohammadi M, Aloyz R, Batist G, Martel S. “Magnetotactic bacteria penetration into multicellular tumor spheroids for targeted therapy.” Conf Proc IEEE Eng Med Biol Soc. 2010;1:4371-4.
Verma S, McLeod D, Batist G, Robidoux A, Martins IR, Mackey JR.” In the end what matters most? A review of clinical endpoints in advanced breast cancer.” Oncologist. 2011;16(1):25-35. Epub 2011 Jan 6.
Support research at the Lady Davis Institute - Jewish General Hospital